Background-Health insurance status at heart transplantation influences recipient survival, but implications of change in insurance for long-term outcomes are unclear. Methods and Results-Adults aged 18 to 64 receiving first-time orthotopic heart transplants between July 2006 and December 2013 were identified in the United Network for Organ Sharing registry. Patients surviving >1 year were categorized according to trajectory of insurance status (private compared with public) at wait listing, transplantation, and 1-year follow-up. The most common insurance trajectories were continuous private coverage (44%), continuous public coverage (27%), and transition from private to public coverage (11%). Among patients who survived to 1 year (n=9088), continuous public insurance (hazard ratio =1.36; 95% confidence interval 1.19, 1.56; P<0.001) and transition from private to public insurance (hazard ratio =1.25; 95% confidence interval 1.04, 1.50; P=0.017) were associated with increased mortality hazard relative to continuous private insurance. Supplementary analyses of 11 247 patients included all durations of post-transplant survival and examined post-transplant private-to-public and public-to-private transitions as time-varying covariates. In these analyses, transition from private to public insurance was associated with increased mortality hazard (hazard ratio =1.25; 95% confidence interval 1.07, 1.47; P=0.005), whereas transition from public to private insurance was associated with lower mortality hazard (hazard ratio =0.78; 95% confidence interval 0.62, 0.97; P=0.024). Conclusions-Transition from private to public insurance after heart transplantation is associated with worse long-term outcomes, compounding disparities in post-transplant survival attributed to insurance status at transplantation. By contrast, post-transplant gain of private insurance among patients receiving publicly funded heart transplants was associated with improved outcomes. (Circ Cardiovasc Qual Outcomes. 2016;9:576-584.
I mproved survival after heart transplantation (HTx) has drawn attention to socioeconomic disparities in the longterm outcomes of this life-saving procedure. [1] [2] [3] [4] In the United States, patients' use of public health insurance (Medicaid and Medicare) predicts worse long-term survival after HTx compared with patients with private insurance. 1, 5 Negative influences of public health insurance use have been attributed to several mechanisms, including limitations on access to posttransplant care and limited coverage of immunosuppression therapy, which increases the risk of rejecting the transplanted organ, leading to graft dysfunction and death. 1, 5 Although insurance status disparities in post-transplant survival have been demonstrated using patients' insurance type at transplantation, 1 it is unclear how trajectories of change in insurance coverage influence outcomes of HTx. In the general population, insurance discontinuity and churn (repeated transitions between public and private insurance) have been linked to reduced access to care and adverse health outcomes. 6 Among transplant recipients, changes in insurance coverage may similarly compromise access to post-transplant care and compliance with medical treatment, leading to increased mortality risk. 7 We test the hypothesis that trajectories of discontinuous insurance coverage predict worse long-term survival after HTx using available data from a national transplant registry. Our secondary aim is to examine whether private-to-public and public-to-private insurance transitions after HTx are associated with overall post-transplant survival.
Editorial, see p 501 Methods
De-identified data on HTx recipients were obtained from the United Network for Organ Sharing (UNOS) registry after approval from Nationwide Children's Hospital Institutional Review Board (IRB14-00716) and a waiver of consent. 8 Adults aged ≥18 years were considered for inclusion if they had received a first-time orthotopic HTx since July 2006 (when broader regional sharing of donor hearts was implemented) until December 2013. In examining transitions between public and private insurance, we were particularly interested in public insurance participation because of low income or disability, but not solely because of older age. Because Medicare enrollment as a result of disability cannot be distinguished from Medicare enrollment on the basis of age among patients aged ≥65 years, we excluded patients aged ≥65 years from the analysis. Patients were excluded if their state of residence at transplantation was unknown. The primary outcome was patient mortality conditional on surviving at least 1 year after transplantation, with follow-up data available through September 2015. The secondary outcome was overall patient survival post-transplant, including survival <1 year.
Insurance status was recoded as private (including self-pay), public (Medicare or Medicaid), or any other type (eg, foreign government, free care). Among patients surviving at least 1 year, we examined insurance status reported at 3 time points: wait listing, transplantation, and the first transplant anniversary. Because the timing of annual follow-up varied among patients, 9 we included the last time point of insurance status only if it was reported within 90 days of the 1-year transplant anniversary. Based on these data, we defined 7 trajectories of insurance coverage: (1) continuous private insurance; (2) continuous public insurance; (3) transition from private to public insurance; (4) transition from public to private insurance; (5) multiple transitions between public and private insurance; (6) any trajectory involving other insurance types; and (7) any trajectory with ≥1 missing data points. Trajectories (3) and (4) implied a single transition from one type of insurance to another (occurring at transplantation or at the first transplant anniversary), whereas trajectory (5) captured patients who transitioned from one type of insurance to another at transplantation, but returned to their previous insurance coverage during follow-up. After describing insurance trajectories based on all available data, the primary analysis of conditional survival excluded patients in trajectories (6) and (7) . Further disaggregation of insurance trajectories according to the type of public insurance (Medicaid versus Medicare) at the 1-year follow-up is examined in the Data Supplement.
Among patients surviving at least 1 year, patient and donor characteristics were compared by insurance trajectory using Chi-square tests for categorical data and analysis of variance for continuous data. Conditional survival analysis used days since transplant as the time metric, with patients entering the analysis on the date of their 1-year follow-up. A Kaplan-Meier plot with a log-rank test illustrated differences in long-term survival across insurance trajectories. Cox proportional hazards models were used to further examine associations between insurance trajectory and long-term survival, accounting for potential confounders. The baseline hazard in Cox regressions was stratified on state of residence at the time of transplantation to account for between-state variability in Medicaid public insurance programs.
Covariates in the analysis were selected according to their plausibility as confounding factors, and included recipient and donor age, recipient and donor sex, recipient-donor sex mismatch, recipientdonor cytomegalovirus matching, recipient race (White, Black, or other), educational attainment (high school or less, some college, or college degree), body mass index, ischemic cardiomyopathy diagnosis, history of prior cardiac surgery, history of dialysis while listed for transplantation, infection in the 2 weeks before the transplant, and quintile of median household income in the ZIP code of permanent residence, based on 2000 Census data. 10 Additional covariates included recipient serum creatinine, serum bilirubin, pulmonary vascular resistance, allograft ischemia time, and left ventricular assist device, extracorporeal membrane oxygenation, intra-aortic balloon pump, mechanical ventilation at transplantation, and donor-recipient size matching, expressed as the difference between donor and recipient predicted heart mass.
11
Multiple imputation by chained equations was used to complete missing data on covariates.
12 Imputations were performed using data from all patients meeting inclusion criteria, regardless of survival time after transplantation. Insurance status, covariates, and outcomes of survival time and mortality were included in the imputation equations. Ten imputed data sets were created and analyzed. Estimates from the 10 imputed data sets were combined according to the rules described by White et al. 12 Each combined unexponentiated coefficient (log hazard ratio) was the average of model coefficients across the 10 imputations, each combined variance of the estimate included within-imputation and between-imputation variance components, and the statistical significance of the combined coefficient was assessed by a t test. 12 After the primary analysis of conditional survival according to insurance trajectory, secondary analyses examined the outcome of overall post-transplant survival, including survival <1 year. The secondary analyses were stratified according to insurance status at transplantation (public versus private). Among recipients of privately insured transplants, the earliest transition to public insurance posttransplant was entered as a piecewise-constant time-varying covariate (ie, equaling 0 until the transition and equaling 1 afterward). Among recipients of publicly insured transplants, the earliest transition to private insurance post-transplant was entered as a piecewise-constant time-varying covariate. The timing of insurance transitions in these analyses was defined as the time a new insurance status was reported to UNOS by the transplant center during follow-up. 13 All analyses were performed in Stata/IC 13.1 (StataCorp LP, College Station, TX). P<0.05 was considered statistically significant, and P values were not adjusted for multiple comparisons.
Results

Study Cohort
The UNOS registry included data on 11 687 first-time HTx performed in adults aged 18 to 64 years between July 2006 and December 2013. Six cases were excluded because of unknown state of residence at transplantation. Multiple imputation to complete data on covariates was performed on all 11 681 remaining cases. In the main analysis, 1392 cases were excluded because of death or censoring within 1 year of the transplant, and the remaining 10 298 cases were classified according to insurance trajectory between listing and the 1-year post-transplant follow-up (including trajectories with incomplete insurance information). For comparison of descriptive statistics and multivariable analysis of conditional survival, a further 1201 cases were excluded if they
WHAT IS KNOWN
• In the United States, health insurance coverage at the time of heart transplantation is associated with longterm graft function and survival outcomes.
• Outcome implications of change in health insurance among transplant recipients are unclear.
WHAT THE STUDY ADDS
• Among adult heart transplant recipients aged 18 to 64 years, the most common change in insurance between wait listing and the first transplant anniversary was transition from private to public insurance.
• Continuous public insurance participation and transition from private to public insurance by 1 year post transplant were associated with lower long-term survival compared with continuous private coverage since the time of wait listing.
• Among adults whose transplant was funded by public insurance, a subsequent transition to private insurance was associated with improved survival.
had incomplete insurance coverage data or if they had a primary payment type other than private insurance, self-pay, Medicaid, or Medicare. Therefore, the multivariable analysis of conditional survival was performed on 9088 cases. In the supplemental analysis of overall post-transplant survival, the sample of 11 681 transplant recipients was reduced to11 247 cases after excluding 434 cases whose primary payment for the transplant was not private insurance, self-pay, Medicare, or Medicaid.
Insurance Trajectories Among Patients Surviving 1 Year
Among 10 298 patients who survived at least 1 year post transplant, median time to 1-year follow-up was 367 days (interquartile range 357, 381), and median survival time was 1482 days (interquartile range 998, 2201). In this cohort, 1475 deaths (14%) were recorded during follow-up. Trajectories of insurance coverage for patients surviving 1 year are shown in Table 1 . The most common trajectories were continuous private coverage (44%), continuous public coverage (27%), and transition from private to public coverage (11%), whereas few patients (299; 3%) experienced multiple transitions between public and private insurance. Patient and donor characteristics were compared across the 5 trajectories involving public or private insurance and including complete data at all time points (Table 2) . Patients with continuous private insurance were particularly likely to be of White race, to have completed college, and to reside in a ZIP code in the top quintile of median household income. The proportion of patients who died during follow-up was lowest among patients who transitioned to private insurance (48/396, 12%) or maintained private insurance from wait listing until the 1-year follow-up (549/4504, 12%). Mortality was most common among patients who remained on public insurance throughout this period (473/2768; 17%). Graft failure because of rejection was also most common in the continuous public insurance group (105/2768; 4%), followed by the group transitioning from private to public insurance (32/1121; 3%), the group transitioning from public to private insurance (9/396; 2%), the continuously privately insured group (98/4504; 2%), and the group with multiple transitions (3/299; 1%). A Chi-square test found statistically significant variation in the occurrence of graft failure because of rejection across insurance trajectories (P<0.001).
Insurance Trajectories and Conditional Survival
A Kaplan-Meier curve demonstrated significant differences in conditional survival by insurance trajectory (Figure; Demographic and clinical factors associated with increased mortality hazard in this analysis included younger recipient age, older donor age, Black recipient race, greater recipient body mass index, dialysis while on the transplant waiting list, a diagnosis of ischemic cardiomyopathy, and prolonged allograft ischemia. To further distinguish among types of public insurance, the multivariable model was repeated while disaggregating the continuous public insurance and private-to-public trajectories by insurance status (Medicaid versus Medicare) at the time of the 1-year followup (Data Supplement). In the continuous public insurance group, an elevated mortality hazard relative to continuous private insurance was observed among patients who participated in Medicaid at the 1-year follow-up (HR=1.69; 95% CI 1.41, 2.03; P<0.001) and among patients who participated in Medicare at the 1-year follow-up (HR=1.21; 95% CI 1.04, 1.42; P=0.014). Examining patients who transitioned from private to public insurance, the increase in mortality hazard reached statistical significance among those who transitioned 
Post-Transplant Insurance Transitions and Overall Survival
Multivariable analyses of overall survival after HTx were performed separately in 6700 patients using private insurance or self-pay at the time of transplantation (Table 4 ) and in 4547 patients using Medicaid or Medicare at the time of transplantation ( 
Discussion
Public insurance payment for HTx is associated with worse post-transplant survival, 1 yet wider provision of public insurance has been proposed to ensure continuity of health insurance coverage for transplant recipients.
14 This study described trajectories of insurance coverage between listing and the first transplant anniversary among HTx recipients and explored associations of health insurance change with post-transplant survival. Continuous public insurance coverage and transitions from private to public insurance coverage were associated with worse long-term survival compared with continuous private insurance coverage, whereas transitions from public insurance to private insurance were associated with improved survival. As transplant recipients' enrollment in public insurance plans is expected to increase in the wake of state Medicaid expansions, 15 outcomes of patients making this transition should be monitored to prevent a widening of insurancerelated disparities in survival after HTx. BMI indicates body mass index; CI, confidence interval; CMV, cytomegalovirus; ECMO, extracorporeal membrane oxygenation; HR, hazard ratio; IABP, intraaortic balloon pump; LVAD, left ventricular assist device; MHI, median household income; pHM, predicted heart mass; PVR, pulmonary vascular resistance. The association of public health insurance with worse long-term patient outcomes has been recognized in cardiac surgery and specifically in HTx. [1] [2] [3] [4] [5] 16, 17 Compared with private insurance plans, public insurance programs may offer lower reimbursement rates, limiting physicians' participation and patients' access to care; 15 offer more limited medication coverage (eg, discontinuing coverage for outpatient immunosuppression medications after a certain time); 18 and may involve churn between eligibility and ineligibility for the public plan. 19 Limitations of public insurance are amplified by high costs of post-transplant care 20 and by high mortality risks among transplant recipients who cannot adhere to posttransplant treatment. 5 Sustained public insurance participation may also contribute to adverse outcomes because of poor access to primary care and worse control of comorbidities. Although mortality in HTx recipients often occurs within the first year post transplant, 21 cumulative disadvantages associated with public insurance participation may be especially relevant for disparities in long-term survival. Stable health insurance coverage is considered essential for patients to be referred for HTx, 20 but survival implications of post-transplant insurance changes are unclear.
Between wait listing and 1-year post-transplant, approximately one fifth of patients experienced at least 1 change in insurance type, and the most common transitions were from private coverage to Medicare or Medicaid. This proportion was somewhat lower than that found in a single-center survey of liver transplant recipients. 22 Compared with patients with continuous private coverage, mortality hazard was 36% higher among patients with continuous public insurance and was also 25% higher among patients who transitioned to public insurance. When differentiating between Medicaid and Medicare insurance, we found that switching to Medicaid was associated with higher mortality hazard compared with continuous private coverage. This is particularly concerning because recent Medicaid expansions may increase transplant recipients' likelihood of switching from private insurance to Medicaid. 13 Furthermore, our findings imply that prior studies' focus on insurance status at transplantation likely underestimated differences in survival between patients with public and private insurance because a portion of patients in the latter group would have lost private coverage soon after transplantation.
Reasons for post-transplant change in insurance status are complex and subject to local variation in labor markets and public insurance eligibility criteria. Paid work offers access to employer-sponsored private insurance, but HTx recipients are unemployed after transplant. 23 In the age range 18 to 64 years, Medicare coverage is available on the basis of work disability, so it is unsurprising that Medicare participation was common, including among patients previously enrolled in private insurance. However, our focus on patients aged <65 years means that our description of patients switching from private to public insurance may not be generalizable to older transplant recipients becoming eligible for Medicare on the basis of age ≥65 years. Although as many as 1 in 3 nonelderly American adults experience discontinuity in health insurance coverage over a 4-year period, 24 few patients in the study cohort had multiple transitions among insurance types. Multiple insurance transitions were associated with worse long-term survival in univariate analysis, but not after multivariable adjustment. The lack of exact data on timing of health insurance changes means that centers may report a change in insurance several months after it happens. Therefore, some cases of multiple transitions in health insurance may have been missed, leading to an inaccurate estimate of the association between multiple insurance transitions and long-term survival. Using UNOS registry data, we have previously identified an association between multiple insurance transitions and diminished survival among lung transplant recipients diagnosed with cystic fibrosis. 7 Detailed data on insurance status transitions, which may be collected via patient surveys, 22 are needed to better understand the influence of multiple insurance transitions on HTx outcomes.
Other limitations of the study constrain the conclusions that may be drawn. Most importantly, the study cohort preceded recent Medicaid expansions to allow analysis of long-term post-transplant survival. Therefore, it is unclear if Medicaid expansion has influenced insurance status among HTx recipients and if this policy influenced associations between insurance status and transplant outcomes. The exclusion of patients who were not transplanted may understate associations between insurance changes and access to HTx. Lack of data on secondary insurance coverage means that the association between Medicare insurance with no secondary coverage and transplant outcomes could not have been isolated in this study. Furthermore, our approach of stratifying the baseline hazards in Cox regression on patients' state of residence meant that we accounted for time-invariant betweenstate differences (eg, differences in Medicaid programs). One limitation of this approach is that we estimated average associations of public insurance with transplant outcomes across all states, rather than examining variability among states in the association between Medicaid program parameters and transplant recipients' survival. Finally, incorrectly entered data, patient loss to follow-up, and the possibility of unobserved confounders are limitations of the analysis that are shared with other work relying on the UNOS registry. 9 Among HTx recipients, changes in health insurance are common between wait listing and the first anniversary of the transplant. Transition from private to public insurance was associated with increased mortality risk after 1 year, whereas transition from public to private insurance was associated with lower mortality hazard when compared with continuous participation in public insurance programs. Because more transplant recipients may rely on public insurance after recent healthcare reforms, 13, 15 determination of optimal insurance coverage for HTx is increasingly urgent for ensuring equity in patient outcomes and effective utilization of scarce donor organs. Our findings demonstrate the need to monitor post-transplant insurance changes among HTx recipients as a potential risk factor for graft failure and mortality. Furthermore, the association between transitions to private insurance and lower post-transplant mortality suggests that protecting access to private insurance after HTx may be explored as an approach to improving long-term transplant outcomes. 
